What is it about?
The world's largest study on the impact of patient blood management on clinical outcomes and its economic consequences
Featured Image
Why is it important?
Blood transfusion is one of the most frequently performed procedures; it crosses many medical disciplines, has been identified as one of the top five overused therapies, and is associated with negative patient outcomes and increased costs. The impact of PBM on patient outcomes and its economic consequences as demonstrated in this study may be substantial considering the global health sector’s challenge to improve patient outcomes with increasingly restricted funding.
Perspectives
This study demonstrates that the coordinated multidisciplinary multi-strategy approach to this new treatment paradigm delivers improved health outcomes to patients while saving substantial health-care costs. Very few initiatives in health today can achieve this win win
Mr Shannon L Farmer
University of Western Australia
Read the Original
This page is a summary of: Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals, Transfusion, February 2017, Wiley,
DOI: 10.1111/trf.14006.
You can read the full text:
Contributors
The following have contributed to this page
